Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Fibroblast Growth Factor 7 5Cisplatin 4avasopasem manganese 3Water 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Injections 2sargramostim 1peppermint oil 1meclocycline 1dusquetide 1clazakizumab 1brilacidin 1anise oil 1Xylitol 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transcutaneous Electric Nerve Stimulation 1Standard of Care 1Sorbic Acid 1Salts 1Saliva, Artificial 1Saline Solution 1RRx-001 1Practice Guidelines as Topic 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Periodontal Debridement 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Stomatitis × brilacidin × Clear all
NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡